Achieve Life (ACHV) news
Recent news
Achieve Life Sciences enters ATM sale agreement with Jefferies for up to $150 mln in common stock - SEC filing
Achieve Life Sciences, Inc. (NASDAQ: ACHV) has entered into an at-the-market (ATM) sale agreement with Jefferies LLC, granting the company the ability to offer and sell shares of its common stock with an aggregate offering price of up to $50 million. The agreement, dated September 27, 2024, allows…
AInvest Wire · Aug 14, 2026Achieve Life Sciences Q2 income from operations USD -18.392 million vs. IBES estimate USD -13.5 million
AInvest Wire · Aug 11, 2026Achieve Life Sciences reports second quarter 2026 financial results and provides business updates
AInvest Wire · Aug 11, 2026Achieve Life Sciences: FDA saw no efficacy, safety deficiencies
AInvest Wire · Jun 22, 2026Achieve Life Sciences - plans NDA resubmission in Q4 2026, potential FDA approval in H1 2027
Achieve Life Sciences Inc. (NASDAQ: ACHV) has outlined plans to resubmit its New Drug Application (NDA) for its lead candidate, ALS-201, in the fourth quarter of 2026. The company has previously submitted the NDA but is currently addressing feedback from the U.S. Food and Drug Administration (FDA)…
AInvest Wire · Jun 22, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.